Cinnarizine 75 Mg Capsules

Cinnarizine 75 Mg Capsules

Description:

Cinnarizine 75 mg capsules are an oral prescription medicine belonging to the antihistamine and antivertigo class (piperazine derivatives). They are primarily used to prevent and treat vertigo, motion sickness, and certain vascular disorders by reducing abnormal stimulation of the vestibular system and improving blood flow in peripheral and cerebral vessels. Each capsule contains cinnarizine as the active ingredient, formulated for adults who require reliable control of dizziness, balance disturbances, nausea, and symptoms related to inner ear and vascular conditions.

Indications:

• Prevention and treatment of motion sickness (travel sickness) associated with nausea, vomiting, and dizziness during travel by car, bus, train, sea, or air.
• Management of vertigo and other vestibular disturbances (e.g., dizziness, balance disorders, tinnitus, and nystagmus) of peripheral origin.
• Adjunctive treatment of vomiting and vertigo associated with Meniere’s disease and other inner ear disorders.
• Treatment of peripheral vascular disorders (e.g., intermittent claudication, Raynaud’s phenomenon, acrocyanosis) as prescribed by a physician.
• Treatment of cerebrovascular disorders (e.g., symptoms related to cerebral circulatory insufficiency such as headache, memory disturbances, lack of concentration, and dizziness) as directed by a healthcare professional.

Active Ingredients / Key Components:

• Cinnarizine – 75 mg per capsule.
• Excipients: The full list of inactive ingredients (capsule shell and fillers) is not available in the provided information. Please refer to the product leaflet or packaging for complete excipient details.

Dosage & Administration / How to Use:

• Route of administration: Oral use only. Swallow the capsule whole with a sufficient amount of water. Do not chew or crush.
• Adults – motion sickness (general guidance based on cinnarizine): 30 mg taken 2 hours before the start of the journey, then 15–30 mg every 8 hours if needed. For this 75 mg strength, dosing and timing must be adjusted and confirmed by your doctor. Do not self-adjust the dose.
• Adults – vertigo and vestibular disturbances: Typical total daily dose for cinnarizine is 90 mg per day in 3 divided doses (e.g., 30 mg three times daily). When using 75 mg capsules, your physician will determine the exact regimen (e.g., 75 mg once or divided as appropriate). Follow medical advice strictly.
• Adults – peripheral and cerebrovascular disorders: Usual dose for cinnarizine is 75 mg 1–3 times daily, as prescribed. Do not exceed the maximum daily dose recommended by your doctor.
• Use with food: It is generally recommended to take cinnarizine after meals to reduce the risk of gastric discomfort.
• Duration of use: Duration depends on the condition being treated and your doctor’s recommendation. Do not use for prolonged periods without medical supervision.
• Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one.
• Special populations: Use in elderly patients, patients with hepatic or renal impairment, and patients with neurological or psychiatric conditions must be carefully monitored by a physician. Not recommended for children unless specifically prescribed by a pediatric specialist.

Clinical Benefits:

• Helps prevent and relieve motion sickness symptoms such as nausea, vomiting, and dizziness during travel.
• Reduces vertigo and balance disturbances by suppressing overactivity of vestibular receptors in the inner ear.
• Provides symptomatic relief in Meniere’s disease and other vestibular disorders, improving daily functioning and comfort.
• Improves peripheral and cerebral blood flow by inhibiting calcium entry into vascular smooth muscle, which may help alleviate symptoms related to circulatory insufficiency.
• May reduce associated symptoms such as headache, tinnitus, and concentration difficulties linked to vestibular or vascular disorders, when used under medical supervision.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity or allergy to cinnarizine or any of the excipients.
• Use with caution in patients with Parkinson’s disease or other extrapyramidal disorders, as cinnarizine may worsen motor symptoms.
• Use with caution in patients with hypotension, severe cardiac disease, hepatic impairment, or renal impairment; dose adjustment and close monitoring may be required.
• May cause drowsiness or reduced alertness. Avoid driving, operating machinery, or performing tasks that require mental alertness until you know how the medicine affects you.
• Avoid concomitant use with alcohol or other central nervous system depressants, as this may increase sedation and dizziness.
• Consult your doctor before use if pregnant or planning pregnancy. Safety in pregnancy is not fully established; use only if clearly needed and prescribed by a physician.
• Consult your doctor before use if breastfeeding, as it is not known whether cinnarizine is excreted in human milk.
• Consult your doctor before use if you are taking other medications, especially other antihistamines, sedatives, antidepressants, antipsychotics, antihypertensives, or antiparkinsonian drugs, due to potential interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: Drowsiness, fatigue, dry mouth, mild gastrointestinal discomfort (nausea, stomach pain, indigestion), weight gain, and headache.
• Less common side effects: Sweating, skin rash or allergic reactions, muscle aches, or mild hypotension (low blood pressure).
• Serious side effects (seek medical attention immediately): Signs of severe allergic reaction (swelling of face, lips, tongue, or throat; difficulty breathing), severe skin reactions, pronounced dizziness or fainting, or new/worsening movement disorders (tremor, rigidity, involuntary movements), especially in patients with Parkinson’s disease.
• If any side effects become severe, persistent, or if you notice any unusual symptoms, stop taking the medicine and contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Do not store above the temperature specified on the pack (refer to the original packaging for exact storage temperature, typically below 25°c or as indicated).

Specifications:

• Strength: 75 mg cinnarizine per capsule.
• Form: Hard gelatin capsule for oral use.
• Pack size: 20 capsules per pack (cinnarizine 75 mg 20 caps as per available data).
• Intended user group: Adults, and only under medical supervision for elderly or special populations.
• Therapeutic class: Antihistamine – antivertigo agent; peripheral and cerebrovascular vasodilator.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.